Shanghai Kinlita Chemical Co., Ltd. (SHE:300225)
China · Delayed Price · Currency is CNY 5.32
-0.06 (-1.12%)
At close: Feb 27, 2026
Shanghai Kinlita Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 759.58 | 715.75 | 718.19 | 616.84 | 832.64 | 873.65 |
Other Revenue | 15.79 | 15.79 | 16.55 | 16.07 | 25.32 | 11.31 |
| 775.37 | 731.54 | 734.74 | 632.91 | 857.96 | 884.96 | |
Revenue Growth (YoY) | 7.42% | -0.43% | 16.09% | -26.23% | -3.05% | 8.78% |
Cost of Revenue | 546.49 | 512.46 | 545.74 | 562.62 | 786.95 | 611.71 |
Gross Profit | 228.88 | 219.08 | 189 | 70.29 | 71.01 | 273.25 |
Selling, General & Admin | 140.28 | 137.05 | 126.51 | 152.45 | 159.31 | 173.5 |
Research & Development | 47.03 | 43.22 | 42.79 | 44.02 | 40.37 | 31.05 |
Other Operating Expenses | 2.72 | 2.35 | 0.65 | 3.4 | 1.36 | 2.62 |
Operating Expenses | 213.42 | 193.21 | 171.59 | 212.53 | 213.49 | 211.47 |
Operating Income | 15.46 | 25.87 | 17.41 | -142.24 | -142.48 | 61.77 |
Interest Expense | -5.31 | -5.56 | -3.05 | -0.28 | -1.18 | -0.39 |
Interest & Investment Income | 11.92 | 8.28 | 0.31 | 13.45 | 0.43 | 30.72 |
Currency Exchange Gain (Loss) | - | - | - | 0 | -0 | - |
Other Non Operating Income (Expenses) | 1.66 | 2.74 | 1.47 | -1.1 | -0.81 | -1.15 |
EBT Excluding Unusual Items | 23.72 | 31.33 | 16.14 | -130.16 | -144.04 | 90.95 |
Impairment of Goodwill | - | - | - | - | -3.85 | - |
Gain (Loss) on Sale of Investments | 0.65 | -0.29 | -0.53 | - | -0.13 | - |
Gain (Loss) on Sale of Assets | -0.43 | -0.68 | 0.42 | -0.15 | -0.23 | -0.27 |
Asset Writedown | 6.01 | - | - | -0.03 | -4.51 | - |
Other Unusual Items | 2.81 | 5.47 | 2.32 | 4.46 | 15.26 | 13.84 |
Pretax Income | 32.76 | 35.83 | 18.35 | -125.88 | -137.5 | 104.51 |
Income Tax Expense | 7.95 | 7.74 | 3.54 | -19.94 | -18.58 | 14.28 |
Earnings From Continuing Operations | 24.8 | 28.09 | 14.81 | -105.94 | -118.92 | 90.23 |
Minority Interest in Earnings | 2.98 | 2.82 | -0.48 | -0.09 | 8.26 | 1.05 |
Net Income | 27.78 | 30.91 | 14.33 | -106.02 | -110.66 | 91.29 |
Net Income to Common | 27.78 | 30.91 | 14.33 | -106.02 | -110.66 | 91.29 |
Net Income Growth | -3.86% | 115.66% | - | - | - | 203.47% |
Shares Outstanding (Basic) | 442 | 442 | 478 | 482 | 481 | 480 |
Shares Outstanding (Diluted) | 442 | 442 | 478 | 482 | 481 | 480 |
Shares Change (YoY) | -5.44% | -7.58% | -0.86% | 0.16% | 0.14% | -4.17% |
EPS (Basic) | 0.06 | 0.07 | 0.03 | -0.22 | -0.23 | 0.19 |
EPS (Diluted) | 0.06 | 0.07 | 0.03 | -0.22 | -0.23 | 0.19 |
EPS Growth | 1.67% | 133.33% | - | - | - | 216.67% |
Free Cash Flow | -14.97 | 98.64 | -21.1 | -204.33 | -231.85 | 107.42 |
Free Cash Flow Per Share | -0.03 | 0.22 | -0.04 | -0.42 | -0.48 | 0.22 |
Dividend Per Share | 0.020 | 0.020 | - | - | - | 0.020 |
Dividend Growth | - | - | - | - | - | 100.00% |
Gross Margin | 29.52% | 29.95% | 25.72% | 11.11% | 8.28% | 30.88% |
Operating Margin | 1.99% | 3.54% | 2.37% | -22.47% | -16.61% | 6.98% |
Profit Margin | 3.58% | 4.23% | 1.95% | -16.75% | -12.90% | 10.32% |
Free Cash Flow Margin | -1.93% | 13.48% | -2.87% | -32.29% | -27.02% | 12.14% |
EBITDA | 35.74 | 51.78 | 50.84 | -108.28 | -109.42 | 91.3 |
EBITDA Margin | 4.61% | 7.08% | 6.92% | -17.11% | -12.75% | 10.32% |
D&A For EBITDA | 20.27 | 25.91 | 33.43 | 33.96 | 33.06 | 29.52 |
EBIT | 15.46 | 25.87 | 17.41 | -142.24 | -142.48 | 61.77 |
EBIT Margin | 1.99% | 3.54% | 2.37% | -22.47% | -16.61% | 6.98% |
Effective Tax Rate | 24.28% | 21.60% | 19.31% | - | - | 13.66% |
Revenue as Reported | 775.37 | 731.54 | 734.74 | 632.91 | 857.96 | 884.96 |
Advertising Expenses | - | - | - | 0.57 | 0.66 | 1.27 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.